Neogen CORP Form 4 insider transactions

John Patrick Moylan, Chief Accounting Officer of Neogen Corp, reported multiple transactions in common stock on August 14, 2026.

Tamara A. Ranalli, Senior Vice President of Neogen Corp, reported multiple transactions in common stock on August 14, 2026.

Jennifer Evans Stacey, Chief Legal Officer of Neogen Corp, reported multiple transactions in common stock on August 14, 2026.

Richard Bryan Riggsbee, CFO of Neogen Corp, reported multiple transactions in common stock on August 14, 2026.

Mikheal Nassif, CEO and a Director of Neogen Corp, reported multiple transactions in common stock on August 14, 2026.

Mikheal Nassif, CEO and a Director of Neogen Corp, purchased 370 shares of common stock on August 4, 2026 for $11.81 per share.

John Patrick Moylan, Chief Accounting Officer of NEOGEN CORP, reported the vesting of 2,553 Restricted Stock Units on June 3, 2026.

Amy Rocklin, former Chief Legal Officer of Neogen Corp, reported transactions involving the accelerated vesting and sale of company stock.

John Patrick Moylan, Chief Accounting Officer of NEOGEN CORP, reported a transaction involving the sale of 4,558 shares of common stock on May 4, 2026.

Neogen Corp's Chief Legal Officer, Jennifer Stacey, acquired 39,349 shares of common stock on May 1, 2026, at a price of $9.53 per share.

NEOGEN CEO Mikheal Nassif's son acquired a total of 49 common shares in two separate transactions in early 2026, with the CEO explicitly disclaiming beneficial ownership.

NEOGEN Senior Vice President Tamara A. Ranalli reported the acquisition of common stock and derivative securities, including options and restricted stock units, with future vesting schedules.

NEOGEN Senior Vice President Tamara A. Ranalli acquired 50,813 shares of common stock and 130,605 derivative securities on January 7, 2026, as part of an equity compensation plan.

NEOGEN Corp's CEO, Mikheal Nassif, disclosed a future acquisition of 137 common shares for his son, disclaiming personal beneficial ownership.

David H. Naemura, former CFO of NEOGEN CORP, increased his beneficial ownership of common stock following the vesting of Restricted Stock Units.

NEOGEN CEO Mikheal Nassif reported the purchase of 177 common shares at $6.25, with indirect beneficial ownership of 495 shares held by his son, though he disclaims beneficial ownership.

NEOGEN's CFO, Richard Bryan Riggsbee, reported the acquisition of 178,855 shares of common stock and 459,713 stock options under a Rule 10b5-1 plan.

NEOGEN Corp. Director James C. Borel acquired 1,777 shares of common stock through the vesting and settlement of Restricted Stock Units.

NEOGEN Director Jeffrey D. Capello converted 1,777 Restricted Stock Units into common stock, increasing his direct ownership.

NEOGEN Director Ronald D Green converted 1,777 Restricted Stock Units into common stock at $6.19 per share, increasing his direct holdings.

NEOGEN Director Aashima Gupta converted 1,777 Restricted Stock Units into common stock on October 27, 2025, increasing her direct beneficial ownership to 27,790 shares.

NEOGEN Director Rafael A. Rodriguez acquired 1,777 shares of common stock through the vesting and settlement of Restricted Stock Units.

NEOGEN Director James P. Tobin converted 1,777 Restricted Stock Units into common stock, increasing his direct beneficial ownership to 43,347 shares.

NEOGEN Director Catherine E Woteki converted 1,777 Restricted Stock Units into common stock on October 27, 2025, increasing her direct beneficial ownership to 19,117 shares.

NEOGEN's Chief Legal Officer, Amy M. Rocklin, reported the vesting of Restricted Stock Units and subsequent stock transactions.

NEOGEN's Chief Financial Officer, David H. Naemura, increased his direct beneficial ownership of common stock by a net of 11,243 shares following the vesting of Restricted Stock Units and subsequent tax withholding.

Douglas Edward Jones, former COO of NEOGEN CORP, exercised 15,504 Restricted Stock Units and sold a portion for tax withholding.

Former NEOGEN CEO John Edward Adent exercised 38,759 Restricted Stock Units, resulting in a net acquisition of 30,232 common shares after tax withholding.

NEOGEN Director William T. Boehm converted 3,553 Restricted Stock Units into common stock on October 27, 2025, increasing his direct beneficial ownership.

NEOGEN Director Jeffrey D. Capello converted 2,025 Restricted Stock Units into common stock on October 27, 2025, increasing his direct ownership.